Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HR 550Session 89R

What changed between versions

9 paragraphs changed+33 words added−5 removed

Highlighted text was added in the newer version. Struck-through text was removed.

89R18840 BK-D

By: Johnson

H.R. No. 550

46 unchanged paragraphs

R E S O L U T I O N

WHEREAS, Dr. Jennifer Keating Litton of The University of

Texas MD Anderson Cancer Center in Houston has distinguished

herself through her many contributions to cancer research and

treatment; and

WHEREAS, Over the course of her tenure at MD Anderson, Dr.

Litton has held numerous leadership positions, including chief of

the Section of Clinical Research and Drug Development in the

Department of Breast Medical Oncology, where she also served as an

associate professor; she has also spearheaded the Breast Medical

Oncology Education Program, the Scientific Review Research

Committee, and the Genitourinary Chair Search Committee; she

currently serves as vice president of clinical research, leading

the largest cancer clinical trials program in the country with more

than 1,500 clinical trials and over 10,000 patients enrolled in

therapeutic trials; moreover, she is a member of the faculty at the

UTHealth Houston Graduate School of Biomedical Sciences at MD

Anderson; and

WHEREAS, Dr. Litton has been involved in numerous committees

and organizations, including the Society for Immunotherapy of

Cancer, the American Society of Clinical Oncology, the Society of

Surgical Oncology, the American Society for Radiation Oncology, the

FORCE Advisory Board, the Clinical Cancer Genetics Steering

Committee, and Living Beyond Breast Cancer; she is also a member of

Suites of Hope in Houston and the Texas Lyceum in Austin; in 2018,

she received the President's Recognition of Faculty Excellence

Award in Prevention Outreach from MD Anderson; and

WHEREAS, Board certified in oncology and internal medicine,

Dr. Litton focuses her research on pregnancy and breast cancer,

genetic testing, and molecular changes of breast cancer genes; she

holds a bachelor's degree from Duke University, a doctor of

medicine degree from the University of Massachusetts Medical

School, and a master's degree in health care management from the

Harvard T. H. Chan School of Public Health; she completed her

residency and chief residency at the Baylor College of Medicine as

well as a fellowship in medical oncology at MD Anderson; and

WHEREAS, Through her leadership, skill, and commitment to

excellence, Dr. Litton has made a lasting and positive impact in her

field, and it is a privilege to join in recognizing this outstanding

professional; now, therefore, be it

RESOLVED, That the House of Representatives of the 89th Texas

Legislature hereby honor Dr. Jennifer Keating Litton for her many

professional achievements and extend to her sincere best wishes for

continued success; and, be it further

RESOLVED, That an official copy of this resolution be

prepared for Dr. Litton as an expression of high regard by the Texas

House of Representatives.

Johnson

______________________________

Speaker of the House

I certify that H.R. No. 550 was adopted by the House on March

31, 2025, by a non-record vote.

______________________________

Chief Clerk of the House

Back to the full text